4.6 Article

Clindamycin to reduce preterm birth in a low resource setting: a randomised placebo-controlled clinical trial

期刊

出版社

WILEY
DOI: 10.1111/1471-0528.15290

关键词

clindamycin; prematurity; vaginal flora

资金

  1. Thrasher Research Foundation, Salt Lake City, UT, USA [10326]

向作者/读者索取更多资源

ObjectiveTo determine whether oral clindamycin reduces the risk of preterm birth (PTB) in women with abnormal vaginal microflora as evidenced by a vaginal pH 5.0. DesignRandomised double-blind placebo-controlled trial. SettingRural southern India. PopulationPregnant women with a singleton fetus between 13(+0/7) weeks and 20(+6/7) weeks. MethodsPregnant women were recruited during prenatal visits in Karnataka, India, from October 2013 to July 2015. Women were required to have a singleton fetus between 13(+0/7) weeks and 20(+6/7) weeks and an elevated vaginal pH (5.0) by colorimetric assessment. Participants were randomised to either oral clindamycin 300 mg twice daily for 5 days or an identical-appearing placebo. Main outcome measuresThe primary outcome was the incidence of PTB, defined as delivery before 37(+0/7) weeks. ResultsOf the 6476 screened women, 1727 women were randomised (block randomised in groups of six; clindamycin n = 866, placebo n = 861). The demographic, reproductive, and anthropomorphometric characteristics of the study groups were similar. Compliance was high, with over 94% of capsules being taken. The rate of PTB before 37 weeks was comparable between the two groups [clindamycin 115/826 (13.9%) versus placebo 111/806 (13.8%), between-group difference 0.2% (95% CI -3.2 to 3.5%, P = 0.93)], as was PTB at less than 34 weeks [clindamycin 40/826 (4.8%) versus placebo group 37/806 (4.6%), between-group difference 0.3% (95% CI -1.8 to 2.3%, P = 0.81)]. No differences were detected in the incidence of birthweight of<2500 g, <1500 g, miscarriage, stillbirth or neonatal death. ConclusionIn this setting, oral clindamycin did not decrease PTB among women with vaginal pH 5.0. Tweetable abstractOral clindamycin between 13(+0/7) and 20(+6/7) weeks does not prevent preterm birth in women with a vaginal pH 5.0. Tweetable abstract Oral clindamycin between 13(+0/7) and 20(+6/7) weeks does not prevent preterm birth in women with a vaginal pH 5.0.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据